Theophylline toxicity: Difference between revisions

No edit summary
Line 38: Line 38:


==Management==
==Management==
#Supportive care
*Supportive care
#*Cardiac monitoring
**Cardiac monitoring
#*Ondansetron (Zofran) for antiemetic
**Ondansetron (Zofran) for antiemetic
#*EEG for sedated and paralyzed patients
**EEG for sedated and paralyzed patients
#Cardiovascular
*Cardiovascular
#*[[IV Fluids]] for [[hypotension]]
**[[IV Fluids]] for [[hypotension]]
#*Beta blockers for [[tachyarrhymias]]
**Beta blockers for [[tachyarrhymias]]
#**[[Esmolol]] particularly wise first-line agent
***[[Esmolol]] particularly wise first-line agent
#**Controversial, involve a toxicologist
***Controversial, involve a toxicologist
#GI decontamination ([[Multidose Activated Charcoal]], [[Whole Bowel Irrigation]])
*GI decontamination ([[Multidose Activated Charcoal]], [[Whole Bowel Irrigation]])
#*Considered in life-threatening overdose
**Considered in life-threatening overdose
#**contraindications: unsecured airway, [[nausea]], [[vomiting]], ileus, [[Bowel Obstruction]], or need for emergent endoscopy
***contraindications: unsecured airway, [[nausea]], [[vomiting]], ileus, [[Bowel Obstruction]], or need for emergent endoscopy
#[[Seizures]]
*[[Seizures]]
#*[[Lorazepam]] (Ativan) 1st line
**[[Lorazepam]] (Ativan) 1st line
#*Phenobarbital if [[lorazepam]] ineffective
**Phenobarbital if [[lorazepam]] ineffective
#*Phenytoin (Dilantin) contraindicated as increases seizure in animal studies
**Phenytoin (Dilantin) contraindicated as increases seizure in animal studies
#Dialysis
*Dialysis
#*Indicated in [[seizures]], severe [[arrhythmias]]
**Indicated in [[seizures]], severe [[arrhythmias]]
#*Theophylline level >90mcg/ml in acute ingestion
**Theophylline level >90mcg/ml in acute ingestion
#*Theophylline level >40mcg/ml in chronic ingestion
**Theophylline level >40mcg/ml in chronic ingestion


==Disposition==
==Disposition==
Line 76: Line 76:


==External Links==
==External Links==


==References==
==References==
<references/>
<references/>
[[Category:Toxicology]]
[[Category:Toxicology]]

Revision as of 19:01, 15 November 2018

See theophylline for general drug information.

Background

  • Still used in patients with debilitating brochospastic disease
  • Studied for treatment of Acute Mountain Sickness and Contrast-Induced Nephropathy
  • PO in elixir, extended release, or controlled release forms but absorption erratic
  • IV as aminophylline
  • Adenosine antagonism, Increase catecholamines, and Phosphodiesterase inhibition

Clinical Features

Differential Diagnosis

Evaluation

  • ECG
  • Chem
  • CK
  • Theophylline level

Management

Disposition

Immediate release

  • Home after 6 hours if:
    • nontoxic
    • asymptomatic
    • and, normal vital sign

Sustained release

  • Home after 12 hours if:
    • nontoxic
    • asymptomatic
    • and, normal vital sign

See Also

External Links

References